scholarly journals Septic Shock in Obstetrics and Gynecology

Author(s):  
Apostolos Kaponis ◽  
Theodoros Filindris ◽  
George Decavalas
1966 ◽  
Vol 96 (7) ◽  
pp. 913-918 ◽  
Author(s):  
Denis Cavanagh ◽  
Allan G.W. McLeod

1969 ◽  
Vol 46 (1) ◽  
pp. 144-148
Author(s):  
Myron Gordon ◽  
Arthur Horowitz

1961 ◽  
Vol 82 (4) ◽  
pp. 742-747 ◽  
Author(s):  
Vincent J. Capraro ◽  
Clyde L. Randall

2019 ◽  
Vol 2 (1) ◽  
pp. 13-21
Author(s):  
Yevhen Grizhimalsky

Despite certain advances in modern medicine, the incidence of inflammatory diseases in women does not decrease, and infectious complications continue to occupy a leading place in the structure of obstetric and gynecological pathology. Moreover, the incidence of such dangerous complications as septic shock tends to increase. Over the past 25 years, the definition of sepsis and septic shock has changed three times; an international intensive care protocol is updated every four years with the participation of dozens of leading organizations and experts. Thus, the urgency of the problem is obvious and requires from doctors of all specialty’s modern knowledge on early detection and timely, early targeted therapy for sepsis and septic shock in obstetrics.


1997 ◽  
Vol 4 (3) ◽  
pp. 124-129 ◽  
Author(s):  
J BISSONNETTE ◽  
S CHAMBERS ◽  
P COLLINS ◽  
C LOCKWOOD ◽  
C MENDELSON ◽  
...  

2006 ◽  
Vol 36 (19) ◽  
pp. 24
Author(s):  
BRUCE JANCIN
Keyword(s):  

Author(s):  
M Algaba Montes ◽  
AÁ Oviedo García ◽  
M Patricio Bordomás

1994 ◽  
Vol 71 (06) ◽  
pp. 768-772 ◽  
Author(s):  
Gerhard Dickneite ◽  
Jörg Czech

SummaryRats which were infected with the gramnegative pathogen Klebsiella pneumoniae develop disseminated intravascular coagulation (DIC), multi-organ failure (MOF) and finally die in a septic shock. We investigated the therapeutic effect of antibiotic (tobramycin) treatment combined with the infusion of the highly specific thrombin inhibitor rec. hirudin. Although administration of 2 mg/kg tobramycin alone leads to a decrease of the bacterial burden, DIC could not be prevented. Infusion of rec. hirudin (0.25 mg/kg x h) for 4 h (start of treatment 1 h post infection), in addition to a bolus administration of tobramycin, led to an amelioration of DIC parameters as fibrinogen, thrombin-antithrombin complex (TAT) and platelets. Serum transaminase levels (GOT, GPT) as a marker of MOF were significantly improved by rec. hirudin, the T50 value increased from 17 h in the tobramycin group to 42 h in the tobramycin + rec. hirudin giuup, muilality rates were 90% or 60%, respectively. Combination of heparin (10011/kg x h) and tobramycin was not effective on survival.


Sign in / Sign up

Export Citation Format

Share Document